Multicenter,Open Label,Phase 2 Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
Latest Information Update: 23 Oct 2023
At a glance
- Drugs Aclarubicin (Primary) ; Azacitidine (Primary) ; Cytarabine (Primary) ; Posaconazole (Primary) ; Tucidinostat (Primary) ; Venetoclax (Primary) ; Voriconazole (Primary) ; Daunorubicin; Granulocyte colony-stimulating factors; Idarubicin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 09 Oct 2023 New trial record